205 related articles for article (PubMed ID: 28247189)
21. Histiocytic sarcoma combined with acute monocytic leukemia: a case report.
Zhao J; Niu X; Wang Z; Lu H; Lin X; Lu Q
Diagn Pathol; 2015 Jul; 10():110. PubMed ID: 26187047
[TBL] [Abstract][Full Text] [Related]
22. Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone.
Becton DL; Kurtzberg J; Kinney TR; Friedman HS; Chaffee S; Falletta JM
Med Pediatr Oncol; 1987; 15(2):58-61. PubMed ID: 3108638
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
[TBL] [Abstract][Full Text] [Related]
24. Central nervous system juvenile xanthogranuloma with malignant transformation.
Orsey A; Paessler M; Lange BJ; Nichols KE
Pediatr Blood Cancer; 2008 Apr; 50(4):927-30. PubMed ID: 17520744
[TBL] [Abstract][Full Text] [Related]
25. Malignant histiocytosis. Complete remission in two pediatric patients.
Simon JH; Tebbi CK; Freeman AI; Green DM; Brecher ML; Barcos M
Cancer; 1987 May; 59(9):1566-70. PubMed ID: 3828956
[TBL] [Abstract][Full Text] [Related]
26. Langerhans cell sarcoma.
Ferringer T; Banks PM; Metcalf JS
Am J Dermatopathol; 2006 Feb; 28(1):36-9. PubMed ID: 16456323
[TBL] [Abstract][Full Text] [Related]
27. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.
Bernard F; Thomas C; Bertrand Y; Munzer M; Landman Parker J; Ouache M; Colin VM; Perel Y; Chastagner P; Vermylen C; Donadieu J
Eur J Cancer; 2005 Nov; 41(17):2682-9. PubMed ID: 16291085
[TBL] [Abstract][Full Text] [Related]
28. [Malignant histiocytosis: study of 8 cases].
Fernández Miranda C; Martínez González MA; Ricard P; Ballestín C; Asso A; Hernández Martínez E; Guerra J; del Palacio A
Med Clin (Barc); 1988 Mar; 90(11):437-42. PubMed ID: 2455200
[No Abstract] [Full Text] [Related]
29. Histiocytic sarcoma in a child-successful management and long-term survival with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sandler G; Franklin A; Hayes-Jordan A
Pediatr Blood Cancer; 2018 Jul; 65(7):e27054. PubMed ID: 29630764
[TBL] [Abstract][Full Text] [Related]
30. Etoposide-based combination chemotherapy in malignant histiocytosis.
Lin FR; Yao EG
J Tongji Med Univ; 1994; 14(4):227-9. PubMed ID: 7760434
[TBL] [Abstract][Full Text] [Related]
31. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.
Kornblau SM; Gandhi V; Andreeff HM; Beran M; Kantarjian HM; Koller CA; O'Brien S; Plunkett W; Estey E
Leukemia; 1996 Oct; 10(10):1563-9. PubMed ID: 8847890
[TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia.
Venditti A; Stasi R; Del Poeta G; Buccisano F; Aronica G; Bruno A; Pisani F; Caravita T; Masi M; Tribalto M
Leukemia; 1995 Jul; 9(7):1121-5. PubMed ID: 7630182
[TBL] [Abstract][Full Text] [Related]
33. [Malignant histiocytosis with complex chromosomal abnormality: successful treatment with CHOP-E chemotherapy].
Mori H; Shimizu T; Harada H; Miyoshi Y; Okada S; Takizawa Y; Niikura H; Terada H; Fujita K
Rinsho Ketsueki; 1991 Mar; 32(3):244-9. PubMed ID: 2041166
[TBL] [Abstract][Full Text] [Related]
34. Cladribine in the treatment of acute myeloid leukemia: a single-institution experience.
Martin MG; Welch JS; Augustin K; Hladnik L; DiPersio JF; Abboud CN
Clin Lymphoma Myeloma; 2009 Aug; 9(4):298-301. PubMed ID: 19717379
[TBL] [Abstract][Full Text] [Related]
35. [Vaginal tumor--an initial manifestation of malignant histiocytosis].
Kneba M; Bergholz M; Schauer A; Nagel GA; Krieger G
Dtsch Med Wochenschr; 1988 Apr; 113(15):602-4. PubMed ID: 3359934
[TBL] [Abstract][Full Text] [Related]
36. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
Gaynor ER; Ultmann JE; Golomb HM; Sweet DL
J Clin Oncol; 1985 Dec; 3(12):1596-604. PubMed ID: 3877790
[TBL] [Abstract][Full Text] [Related]
37. A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.
Vogler WR; McCarley DL; Stagg M; Bartolucci AA; Moore J; Martelo O; Omura GA
Leukemia; 1994 Nov; 8(11):1847-53. PubMed ID: 7967730
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis].
Wang WQ; Ge J; Ma HH; Lian HY; Cui L; Zhang L; Li ZG; Wang TY; Zhang R
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1118-1123. PubMed ID: 38018049
[No Abstract] [Full Text] [Related]
39. [Collision tumor of small lymphocytic lymphoma and histiocytic sarcoma: report of a case].
Gao LX; Liu G; Yang GZ; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):775. PubMed ID: 20079020
[No Abstract] [Full Text] [Related]
40. Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial).
Willemze R; Suciu S; Muus P; Halkes CJ; Meloni G; Meert L; Karrasch M; Rapion J; Vignetti M; Amadori S; de Witte T; Marie JP
Ann Hematol; 2014 Jun; 93(6):965-75. PubMed ID: 24682421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
